EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recombinant EHV-1 Vector Expressing Immunodominant Hemagglutinin Protein of Equine Influenza Virus H3N8 (Sub-Lineage Florida Clade 2)

Bidhan Chandra Bera iD, Manju Bernela, Aashwina Madhwal, Stephanie S Pradhan, Venkataramireddy Balena, Taruna Anand, Supriya Kandasamy, Selvaraj Pavulraj, Wandit Ahlawat, Diksha Kandpal, Priya Mor, Gurmesh Bishnoi und 4 weitere

Vaccines · 20.07.2026 · 14 (7) · 634

DOI: 10.3390/vaccines14070634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 20.07.2026. Verfasst von Bidhan Chandra Bera und 15 weiteren Autor:innen. Beteiligte Einrichtung: ICAR-National Research Centre on Equines, Sirsa Road, Hisar 125001, Haryana, India. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ICAR National Science Agriculture Fund, Indian Council of Agricultural Research, Department of Agricultural Research and Education (DARE), Ministry of Agriculture and Farmers Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Equine herpesvirus type 1 (EHV-1) and equine influenza virus (EIV) are major respiratory pathogens in horses, causing significant economic losses in domesticated horses. Bacterial Artificial Chromosome (BAC) technology can be used to precisely manipulate the EHV-1 genome for the development of live-attenuated vector vaccines. Earlier, our group developed a live-attenuated EHV-1 vaccine by deleting virulence-associated genes using this technology and the mutant EHV-1 has been exploited for expressing foreign gene in the current study. Specifically, in this study, a mutant EHV-1 virus expressing the hemagglutinin (HA) gene of H3N8 EIV (sub-lineage: Florida clade 2) was generated and characterized in vitro.

Methods

The HA gene of EIV (Florida clade 2) was used for antigen gene cloning. The expression cassette for the HA gene was commercially synthesized and inserted into the backbone of EHV1∆IR6 BAC using an En passant mutagenesis strategy. Recombinant clones were selected using antibiotic selection, PCR, and RFLP. Further, the recombinant virus was regenerated in RK-13 cells via transfection and characterized in vitro for plaque size, growth kinetics and immunofluorescence antibody test (IFAT).

Results

PCR and RFLP confirmed the successful insertion of the HA gene into pEHV1∆IR6/gE BAC. The recombinant virus, vEHV1∆IR6/gE-HA(FC2), was successfully rescued in RK13 cells and demonstrated expression of the EIV haemagglutinin proteins by immunofluorescence assay. Although plaque size was reduced in the generated mutant virus in comparison to parental virus, the growth kinetics of the recombinant viruses were comparable to those of vEHV1∆IR6/gE.

Conclusions

These findings demonstrate the successful expression of immunodominant hemagglutinin protein of EIV by recombinant EHV-1 and indicate the potential suitability of EHV-1 BAC as a vector platform for foreign gene expression.

Schlagwörter

Stichwörter der Autor:innen

EHV-1 vectored vaccinebivalent vaccineequine influenza virusmutagenesis

Autor:innen und Institutionen

  • ICAR-National Research Centre on Equines, Sirsa Road, Hisar 125001, Haryana, India.
  • Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly 243122, Uttar Pradesh, India.
  • Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
  • Indian Council of Agricultural Research, Krishi Bhawan, New Delhi 110012, Delhi, India.

ORCID-Profile: Bidhan Chandra Bera, Tarun Kumar Bhattacharya, Nitin Virmani

Förderung

  • ICAR National Science Agriculture Fund
  • Indian Council of Agricultural Research
  • Department of Agricultural Research and Education (DARE), Ministry of Agriculture and Farmers Welfare

Zitieren

APA

Bera, B. C., Bernela, M., Madhwal, A., Pradhan, S. S., Balena, V., Anand, T., Kandasamy, S., Pavulraj, S., Ahlawat, W., Kandpal, D., Mor, P., Bishnoi, G., Vasdev, N., Tripathi, B. N., Bhattacharya, T. K., & Virmani, N. (2026). Recombinant EHV-1 Vector Expressing Immunodominant Hemagglutinin Protein of Equine Influenza Virus H3N8 (Sub-Lineage Florida Clade 2). Vaccines, 14(7), 634. https://doi.org/10.3390/vaccines14070634

Vancouver

Bera BC, Bernela M, Madhwal A, Pradhan SS, Balena V, Anand T, et al. Recombinant EHV-1 Vector Expressing Immunodominant Hemagglutinin Protein of Equine Influenza Virus H3N8 (Sub-Lineage Florida Clade 2). Vaccines. 2026;14(7):634. doi:10.3390/vaccines14070634

BibTeX
@article{Bera2026,
  author = {Bera, Bidhan Chandra and Bernela, Manju and Madhwal, Aashwina and Pradhan, Stephanie S and Balena, Venkataramireddy and Anand, Taruna and Kandasamy, Supriya and Pavulraj, Selvaraj and Ahlawat, Wandit and Kandpal, Diksha and Mor, Priya and Bishnoi, Gurmesh and Vasdev, Nishant and Tripathi, Bhupendra Nath and Bhattacharya, Tarun Kumar and Virmani, Nitin},
  title = {Recombinant EHV-1 Vector Expressing Immunodominant Hemagglutinin Protein of Equine Influenza Virus H3N8 (Sub-Lineage Florida Clade 2)},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {7},
  pages = {634},
  doi = {10.3390/vaccines14070634}
}
Kostenlos starten →